Cargando…

Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior

The variability of the COVID-19 vaccination effectiveness (VE) should be assessed with a resolution of a few days, assuming that the VE is influenced by public behavior and social activity. Here, the VE for the Omicron variants (BA.2 and BA.5) is numerically derived for Japan’s population for the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodera, Sachiko, Niimi, Yuki, Rashed, Essam A., Yoshinaga, Naoki, Toyoda, Masashi, Hirata, Akimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694407/
https://www.ncbi.nlm.nih.gov/pubmed/36366329
http://dx.doi.org/10.3390/vaccines10111820
_version_ 1784837792487964672
author Kodera, Sachiko
Niimi, Yuki
Rashed, Essam A.
Yoshinaga, Naoki
Toyoda, Masashi
Hirata, Akimasa
author_facet Kodera, Sachiko
Niimi, Yuki
Rashed, Essam A.
Yoshinaga, Naoki
Toyoda, Masashi
Hirata, Akimasa
author_sort Kodera, Sachiko
collection PubMed
description The variability of the COVID-19 vaccination effectiveness (VE) should be assessed with a resolution of a few days, assuming that the VE is influenced by public behavior and social activity. Here, the VE for the Omicron variants (BA.2 and BA.5) is numerically derived for Japan’s population for the second and third vaccination doses. We then evaluated the daily VE variation due to social behavior from the daily data reports in Tokyo. The VE for the Omicron variants (BA.1, BA.2, and BA.5) are derived from the data of Japan and Tokyo with a computational approach. In addition, the effect of the different parameters regarding human behavior on VE was assessed using daily data in Tokyo. The individual VE for the Omicron BA.2 in Japan was 61% (95% CI: 57–65%) for the second dose of the vaccination from our computation, whereas that for the third dose was 86% (95% CI: 84–88%). The individual BA.5 VE for the second and third doses are 37% (95% CI: 33–40%) and 63% (95% CI: 61–65%). The reduction in the daily VE from the estimated value was closely correlated to the number of tweets related to social gatherings on Twitter. The number of tweets considered here would be one of the new candidates for VE evaluation and surveillance affecting the viral transmission.
format Online
Article
Text
id pubmed-9694407
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96944072022-11-26 Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior Kodera, Sachiko Niimi, Yuki Rashed, Essam A. Yoshinaga, Naoki Toyoda, Masashi Hirata, Akimasa Vaccines (Basel) Article The variability of the COVID-19 vaccination effectiveness (VE) should be assessed with a resolution of a few days, assuming that the VE is influenced by public behavior and social activity. Here, the VE for the Omicron variants (BA.2 and BA.5) is numerically derived for Japan’s population for the second and third vaccination doses. We then evaluated the daily VE variation due to social behavior from the daily data reports in Tokyo. The VE for the Omicron variants (BA.1, BA.2, and BA.5) are derived from the data of Japan and Tokyo with a computational approach. In addition, the effect of the different parameters regarding human behavior on VE was assessed using daily data in Tokyo. The individual VE for the Omicron BA.2 in Japan was 61% (95% CI: 57–65%) for the second dose of the vaccination from our computation, whereas that for the third dose was 86% (95% CI: 84–88%). The individual BA.5 VE for the second and third doses are 37% (95% CI: 33–40%) and 63% (95% CI: 61–65%). The reduction in the daily VE from the estimated value was closely correlated to the number of tweets related to social gatherings on Twitter. The number of tweets considered here would be one of the new candidates for VE evaluation and surveillance affecting the viral transmission. MDPI 2022-10-28 /pmc/articles/PMC9694407/ /pubmed/36366329 http://dx.doi.org/10.3390/vaccines10111820 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kodera, Sachiko
Niimi, Yuki
Rashed, Essam A.
Yoshinaga, Naoki
Toyoda, Masashi
Hirata, Akimasa
Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title_full Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title_fullStr Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title_full_unstemmed Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title_short Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
title_sort estimation of mrna covid-19 vaccination effectiveness in tokyo for omicron variants ba.2 and ba.5: effect of social behavior
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694407/
https://www.ncbi.nlm.nih.gov/pubmed/36366329
http://dx.doi.org/10.3390/vaccines10111820
work_keys_str_mv AT koderasachiko estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior
AT niimiyuki estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior
AT rashedessama estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior
AT yoshinaganaoki estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior
AT toyodamasashi estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior
AT hirataakimasa estimationofmrnacovid19vaccinationeffectivenessintokyoforomicronvariantsba2andba5effectofsocialbehavior